Hurley Consulting Associates Ltd. is an international consulting company serving the health sciences industry. We provide an integrated approach to the product development process and commercial planning in order to define the best target indications to balance medical needs in the context of reimbursement requirements. We have substantial experience in identifying competitive characteristics that optimally position products. We aid clients in their commercial strategies, which include compound selection as well as technical and commercial evaluation of product and company acquisition candidates and licensing opportunities. We are recognized within the health sciences industry for the high level of our expertise and the excellent quality of our work.

Hurley Consulting offers clients a broad range of consulting expertise together with comprehensive contract research services. Our services range from preclinical assessments, clinical trial design, data analysis, regulatory strategy and dossier submissions, to outcomes research, reimbursement strategies, and marketing assessments. We unite the strategy, planning, and analytical expertise needed for product development and/or evaluation of business opportunities. Consulting is offered on a fee-for-service basis.

Hurley Consulting has been instrumental in aiding both leading international corporations and smaller pharmaceutical and biotechnology companies with product development programs. We have assisted clients in the preparation of product registration dossiers for submission in the United States, Europe, and Canada, resulting in the approval of new drug products, line extensions, diagnostic agents, and devices.

With a commitment to quality and timeliness, Hurley Consulting works with clients to meet their corporate objectives. We work closely with sponsors to evaluate data in the context of health authority regulations, the market environment, and pricing authority requirements. We work with and represent sponsors in discussions with health and reimbursement authorities and third-party payers.